試題詳解

68. 依據 2023 AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma，下列何者敘述正確？
(1) AASLD advises against the combination of systemic therapy with
transarterial therapies for BCLC Stage B HCC outside of a clinical trial setting
(2) Patients with BCLC Stage B HCC should be treated with transarterial
chemoembolization
(3) AASLD advises radioembolization as an alternative therapy to
chemoembolization in patients with BCLC Stage B HCC
(4) Patients with Child-Turcotte-Pugh class C cirrhosis should be enrolled in
surveillance programs
(A) (3)＋(4)
(B) (1)＋(2)
(C) (3)
(D) (1)＋(2)＋(3)

(E) (1)＋(2)＋(3)＋(4)